首页TWST • NASDAQ
add
Twist Bioscience Corp
昨日收盘价
$31.70
当日价格范围
$31.22 - $31.80
年度波幅
$23.30 - $55.33
市值
19.35亿 USD
平均交易量
185.23万
市盈率
-
股息率
-
主要交易所
NASDAQ
相关资讯
财务信息
损益表
收入
净收入
| (USD) | 2025年9月info | 年同比变化 |
|---|---|---|
收入 | 9900.90万 | 16.88% |
经营支出 | 8077.10万 | 8.74% |
净收入 | -2713.80万 | 21.69% |
净利润率 | -27.41 | 33.00% |
每股收益 | -0.45 | 23.73% |
息税折旧摊销前利润 | -2683.00万 | 16.12% |
有效税率 | -0.96% | — |
资产负债表
总资产
负债总额
| (USD) | 2025年9月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 2.32亿 | -15.91% |
总资产 | 6.42亿 | 4.48% |
负债总额 | 1.69亿 | 19.25% |
权益总额 | 4.73亿 | — |
发行在外的股份 | 6114.80万 | — |
市净率 | 4.06 | — |
资产回报率 | -11.64% | — |
资本回报率 | -13.19% | — |
现金流
现金净变动
| (USD) | 2025年9月info | 年同比变化 |
|---|---|---|
净收入 | -2713.80万 | 21.69% |
来自运营的现金 | -1181.40万 | 22.89% |
投资现金 | -1240.30万 | -865.21% |
融资现金 | 557.40万 | 53.68% |
现金净变动 | -1848.00万 | -43.20% |
自由现金流 | -1458.78万 | -124.74% |
简介
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
CEO
成立时间
2013
员工数量
979
